home / stock / okyo / okyo quote
Last: | $1.49 |
---|---|
Change Percent: | -4.13% |
Open: | $1.4475 |
Close: | $1.49 |
High: | $1.49 |
Low: | $1.35 |
Volume: | 14,718 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.49 | $1.4475 | $1.49 | $1.49 | $1.35 | 14,718 | 05-31-2024 |
$1.3901 | $1.46 | $1.3901 | $1.48 | $1.3901 | 6,159 | 05-30-2024 |
$1.4396 | $1.26 | $1.4396 | $1.49 | $1.26 | 17,155 | 05-29-2024 |
$1.3105 | $1.32 | $1.3105 | $1.42 | $1.21 | 19,519 | 05-28-2024 |
$1.32 | $1.33 | $1.32 | $1.4775 | $1.27 | 40,270 | 05-27-2024 |
$1.32 | $1.33 | $1.32 | $1.4775 | $1.27 | 40,270 | 05-24-2024 |
$1.4841 | $1.455 | $1.4841 | $1.54 | $1.4 | 6,451 | 05-23-2024 |
$1.4931 | $1.4 | $1.4931 | $1.529 | $1.4 | 4,590 | 05-22-2024 |
$1.47 | $1.47 | $1.47 | $1.47 | $1.46 | 1,135 | 05-21-2024 |
$1.49 | $1.48 | $1.49 | $1.55 | $1.48 | 2,389 | 05-20-2024 |
$1.52 | $1.51 | $1.52 | $1.58 | $1.4639 | 11,905 | 05-17-2024 |
$1.55 | $1.44 | $1.55 | $1.57 | $1.44 | 34,750 | 05-16-2024 |
$1.49 | $1.41 | $1.49 | $1.5 | $1.41 | 10,912 | 05-15-2024 |
$1.51 | $1.46 | $1.51 | $1.51 | $1.4 | 248,816 | 05-14-2024 |
$1.48 | $1.49 | $1.48 | $1.49 | $1.3571 | 9,104 | 05-13-2024 |
$1.46 | $1.4095 | $1.46 | $1.4947 | $1.4095 | 1,859 | 05-10-2024 |
$1.51 | $1.41 | $1.51 | $1.5175 | $1.41 | 3,225 | 05-09-2024 |
$1.48 | $1.4033 | $1.48 | $1.49 | $1.4001 | 4,870 | 05-08-2024 |
$1.4242 | $1.455 | $1.4242 | $1.47 | $1.42 | 3,270 | 05-07-2024 |
$1.49 | $1.51 | $1.49 | $1.51 | $1.44 | 11,477 | 05-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
OKYO Pharma Limited Company Name:
OKYO Stock Symbol:
NASDAQ Market:
LONDON and NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases ...
LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment disease...
LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing...